Health Minister: Covid-19 treatment medication Paxlovid to enter Georgia this week
The Coordination Council, the state body overseeing Covid-related regulations and restrictions in Georgia, said earlier today Georgia would be the first country in the region to receive the novel treatment for Covid-19. Photo: ajaratv.ge
Tweet 
Share
Georgia will receive Paxlovid, a Covid-19 treatment medication created by Pfizer, starting this week, Georgian Health Minister Zurab Azarashvili announced on Tuesday.
Azarashvili said Georgia was among several countries worldwide receiving the medication for the virus, adding the medicine would be free for the patients whose condition might be “potentially aggravated” due to the infection, as well as those with chronic illnesses.
He further said it was necessary to take the medicine during the first five days after a confirmed case of the virus.
The Coordination Council, the state body overseeing Covid-related regulations and restrictions in Georgia, said earlier today Georgia would be the first country in the region to receive the novel treatment for Covid-19.
Wearing a face mask in outdoor spaces will no longer be mandatory across Georgia starting March 28, Giorgi Ghibradze of the Interagency Coordination Council announced earlier today.
Georgia has reported 1,053 new Covid-19 cases, 2,067 recoveries, and seven deaths in the past 24 hours. The positivity rate for the last 14 days stands at 7.19 percent. Overall 25,013 remain infected with coronavirus in Georgia.
Daily confirmed cases of Covid-19 in Georgia have decreased 24 times, while the cases of hospitalisation have dropped 12 times compared to data from February, the Health Ministry announced on Wednesday.
Georgia will import a new batch of the Pfizer vaccine against Covid-19 by the end of March, Health Minister Zurab Azarashvili said at today’s Government session.
Georgia will receive up to 50,000 doses of the Pfizer vaccine for Covid-19, designated for children aged between five and 12, in the second quarter of this year, the head of the National Center for Disease Control Amiran Gamkrelidze announced today.
Preliminary findings of a National Centre for Disease Control (NCDC) study has found about 85 percent of the Georgian population to have developed immunity against Covid-19, Amiran Gamkrelidze, the Head of the NCDC, said on Tuesday.
Georgia has reported 817 new Covid-19 cases, 3,017 recoveries, and three deaths in the past 24 hours. The positivity rate for the last 14 days stands at 6.64 percent. Overall 22,810 remain infected with coronavirus in Georgia.
Georgia has reported 599 new Covid-19 cases, 3,846 recoveries, and seven deaths in the past 24 hours. The positivity rate for the last 14 days stands at 5.73 percent. Overall 19,556 remain infected with coronavirus in Georgia.
Georgia has reported 590 new Covid-19 cases, 3,247 recoveries, and 10 deaths in the past 24 hours. The positivity rate for the last 14 days stands at 5.14 percent. Overall 16,889 remain infected with coronavirus in Georgia.
Georgia has reported 553 new Covid-19 cases, 1,021 recoveries, and nine deaths in the past 24 hours. The positivity rate for the last 14 days stands at 3.65 percent. Overall 7,578 remain infected with coronavirus in Georgia.
Georgia has reported 407 new Covid-19 cases, 1,303 recoveries, and three deaths in the past 24 hours. The positivity rate for the last 14 days stands at 3.2 percent. Overall 5,583 remain infected with coronavirus in Georgia.
Georgia has reported 578 new Covid-19 cases, 389 recoveries, and three deaths in the past 24 hours. The positivity rate for the last 14 days stands at 2.61 percent. Overall 4,189 remain infected with coronavirus in Georgia.
Tengiz Tsertsvadze, the head of the Infectious Diseases and AIDS Centre in Tbilisi, has urged the public to get their Covid-19 vaccines or its booster doses, saying the pandemic was “not fully over yet”.
Ivane Chkhaidze, the medical director of Iashvili children’s hospital on Saturday said the “overwhelming” majority of flu cases have been the so-called Hong Kong H3-N2 virus, which appears to be more severe in children, unlike the current coronavirus variant.